Meet our expert scientists to learn about our recent advances in preclinical drug evaluation, which includes new humanized animal models, antibody drug development (via RenMice), and in vivo/in vitro preclinical pharmacology studies.
Whether you’re generating custom models or testing novel therapeutic candidates, we’d love to chat with you to find out how we can advance your research program.
Preclinical Evaluation of Novel Combination Therapies Using Multigenic Humanized Models
Date: July 14th, 2022
Time: 4:50 PM (EDT)
Speaker: Jenna Frame, PhD, Sr. Manager, Scientific Communications and Marketing
What we’ll cover: